Administrative Core
行政核心
基本信息
- 批准号:10249109
- 负责人:
- 金额:$ 36.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAdvisory CommitteesAnimal ModelAnimalsAntidotesArsenicalsBioinformaticsBiometryBullaCenters of Research ExcellenceChemicalsCollaborationsCommunicationConsultationsCore FacilityCutaneousDataEducationEnsureEpigenetic ProcessEthicsEvaluationExposure toFosteringGoalsHealth PersonnelHistone AcetylationHuman ResourcesIndividualInflammationInjuryInjury to KidneyIraqJointsKidneyLeadLeadershipLungMissionMolecularMustard AgentPathogenesisPathogenicityPathologicPopulationPre-Clinical ModelProductivityProtective AgentsQuality ControlRecommendationRegulationReportingResearchResearch PersonnelResource AllocationScientistServicesStudentsSyriaTherapeutic InterventionTimeTissuesToxic effectToxicologyTreatment EfficacyUnited States National Institutes of HealthVesicantsWarWorld War IIbasechemical threatconflict resolutiondiphenyldrug developmentdrug discoveryfirst responderlewisitemeetingsmultidisciplinaryoperationprogramsresponseservice utilizationskin lesionsmall moleculesmall molecule inhibitorsmall molecule therapeuticssoundspatiotemporalweapons
项目摘要
Abstract (Administrative Core)
The goal of the Administrative Core is to coordinate the scientific, operational, and financial operations of the
entire U54 Center of Excellence. Dr. Mohammad Athar will lead the Administrative Core and will be assisted by
the leaders of the individual projects and by the core directors. The Internal and External Advisory Committees
will offer additional advice to the Administrative Core on the scientific direction of each of the projects and the
scientific cores. The Administrative Core will provide the necessary leadership, oversight, direction, and
administrative support services necessary for the timely and ethical conduction of research related to this U54
Center of Excellence. In addition, the Administrative Core will reduce the time Project and Core leaders and
other personnel need to spend on administrative details, and allow them to concentrate on the scientific goals of
the center. The Core also will facilitate interaction and communication between components of the U54 Center
of Excellence. The Administrative Core will accomplish this with the following responsibilities: 1. To plan,
coordinate and implement the administrative activities of the Projects and Cores, and to maintain sound fiscal
management of the Projects and Cores. 2. To provide oversight to the core facilities by assuring high quality and
adequate utilization of the services provided, and to evaluate resource allocation to all projects and cores. 3. To
promote productive interactions between the Projects and Cores and to foster communication that will enhance
the exchange of ideas between Project and Core scientists. 4. To coordinate evaluation by the Internal and
External Advisory Committees. 5. To interface with officials at UAB, the National Institute of Health CounterACT
Program and other regulatory agencies to ensure that there is Institutional and NIH Compliance. To coordinate
regular meetings project and core leaders. The Administrative Core will provide regular reports to the NIH
CounterACT Program on the progress of this U54 Center of Excellence. 6. To coordinate biostatistical and
bioinformatics activities to ensure that investigators have ready access to statistical/bioinformatics consultation
and support. Additional important duties of the Administrative Core will be to provide strict fiscal oversight and
to help with conflict resolution and if any should occur to resolve them in a timely manner. Finally, to also have
oversight on quality control.
摘要(行政核心)
行政核心的目标是协调科学、运营和财务运作
整个 U54 卓越中心。 Mohammad Athar 博士将领导行政核心,并得到以下人员的协助:
各个项目的领导者和核心董事。内部和外部咨询委员会
将就每个项目的科学方向和
科学核心。行政核心将提供必要的领导、监督、指导和
及时且合乎道德地开展与该 U54 相关的研究所需的行政支持服务
卓越中心。此外,行政核心将减少项目和核心领导者和
其他人员需要花在行政细节上,让他们专注于科学目标
中心。该核心还将促进 U54 中心各组成部分之间的交互和通信
卓越。行政核心将通过以下职责来完成这一任务: 1. 规划、
协调和实施项目和核心的行政活动,并保持健全的财政
项目和核心的管理。 2、对核心设施进行监督,确保高质量和高品质
充分利用所提供的服务,并评估所有项目和核心的资源分配。 3. 到
促进项目和核心之间富有成效的互动,并促进沟通,从而增强
项目和核心科学家之间的思想交流。 4.协调内部和外部评估
外部咨询委员会。 5. 与 UAB、国立卫生研究院 CounterACT 的官员联系
计划和其他监管机构,以确保机构和 NIH 合规性。协调
定期召开项目及核心领导会议。行政核心将定期向 NIH 提供报告
关于 U54 卓越中心进展的 CounterACT 计划。 6. 协调生物统计和
生物信息学活动,以确保研究人员能够随时获得统计/生物信息学咨询
和支持。行政核心的其他重要职责是提供严格的财政监督和
帮助解决冲突,如果发生冲突,及时解决。最后,还要有
质量控制监督。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohammad Athar其他文献
Mohammad Athar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohammad Athar', 18)}}的其他基金
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
砷皮肤损伤新型分子靶点药物的优化
- 批准号:
10700044 - 财政年份:2020
- 资助金额:
$ 36.57万 - 项目类别:
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
砷皮肤损伤新型分子靶点药物的优化
- 批准号:
10886403 - 财政年份:2020
- 资助金额:
$ 36.57万 - 项目类别:
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
砷皮肤损伤新型分子靶点药物的优化
- 批准号:
10023318 - 财政年份:2020
- 资助金额:
$ 36.57万 - 项目类别:
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury
砷皮肤损伤新型分子靶点药物的优化
- 批准号:
10259711 - 财政年份:2020
- 资助金额:
$ 36.57万 - 项目类别:
UAB Research Center of Excellence in Arsenicals
阿拉巴马大学砷化合物卓越研究中心
- 批准号:
9767149 - 财政年份:2018
- 资助金额:
$ 36.57万 - 项目类别:
UAB Research Center of Excellence in Arsenicals
阿拉巴马大学砷化合物卓越研究中心
- 批准号:
10249107 - 财政年份:2018
- 资助金额:
$ 36.57万 - 项目类别:
Core 4: Animal Breeding (UAB) and Exposure Core (MRIGLOBAL)
核心 4:动物育种 (UAB) 和暴露核心 (MRIGLOBAL)
- 批准号:
10249112 - 财政年份:2018
- 资助金额:
$ 36.57万 - 项目类别:
Project 1: Novel Pharmacological Inhibitors of Chemical Vesicants-mediated Cutaneous Injury
项目1:化学糜烂介导的皮肤损伤的新型药理抑制剂
- 批准号:
10249113 - 财政年份:2018
- 资助金额:
$ 36.57万 - 项目类别:
Core 3: Rexinoid Screening and Animal Core
核心 3:Rexinoid 筛选和动物核心
- 批准号:
10007604 - 财政年份:2017
- 资助金额:
$ 36.57万 - 项目类别:
Core 3: Rexinoid Screening and Animal Core
核心 3:Rexinoid 筛选和动物核心
- 批准号:
10263928 - 财政年份:2017
- 资助金额:
$ 36.57万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The role of gut-heart axis in acute alcohol intoxication-induced adverse cardiovascular events
肠心轴在急性酒精中毒诱发的不良心血管事件中的作用
- 批准号:
10847617 - 财政年份:2023
- 资助金额:
$ 36.57万 - 项目类别:
Validation of Video Administration of a Modified UDSv3 Cognitive Battery
改进的 UDSv3 认知电池的视频管理验证
- 批准号:
10577828 - 财政年份:2022
- 资助金额:
$ 36.57万 - 项目类别:
Investigation of enterovirus D68 pathogenesis in the human spinal cord
肠道病毒 D68 在人脊髓中发病机制的研究
- 批准号:
10661096 - 财政年份:2022
- 资助金额:
$ 36.57万 - 项目类别:
Validation of Video Administration of a Modified UDSv3 Cognitive Battery
改进的 UDSv3 认知电池的视频管理验证
- 批准号:
10370578 - 财政年份:2022
- 资助金额:
$ 36.57万 - 项目类别:
Investigation of enterovirus D68 pathogenesis in the human spinal cord
肠道病毒 D68 在人脊髓中发病机制的研究
- 批准号:
10506843 - 财政年份:2022
- 资助金额:
$ 36.57万 - 项目类别: